![](/img/cover-not-exists.png)
584 POSTER Histone deacetylase inhibitors abrogate the levels and activity of estrogen receptor (ER) α and histone deacetylase (HDAC) 6 in human breast cancer cells (BCCs)
W. Fiskus, A. Mohapatra, P. Bali, M. Balasis, R. Rao, P. Atadja, J. Wu, K. BhallaVolume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)70589-4
File:
PDF, 60 KB
english, 2006